Wells Fargo’s Inovio Pharmaceuticals INO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.97K Sell
967
-21,402
-96% -$43.6K ﹤0.01% 5757
2025
Q1
$36.5K Buy
22,369
+5,681
+34% +$9.26K ﹤0.01% 5044
2024
Q4
$30.5K Buy
16,688
+3,238
+24% +$5.93K ﹤0.01% 5144
2024
Q3
$77.7K Buy
13,450
+333
+3% +$1.93K ﹤0.01% 4759
2024
Q2
$106K Buy
13,117
+11,618
+775% +$93.9K ﹤0.01% 4548
2024
Q1
$20.8K Sell
1,499
-322
-18% -$4.47K ﹤0.01% 5182
2023
Q4
$11.1K Buy
1,821
+261
+17% +$1.6K ﹤0.01% 5368
2023
Q3
$7.28K Sell
1,560
-165
-10% -$770 ﹤0.01% 5501
2023
Q2
$9.24K Sell
1,725
-35,217
-95% -$189K ﹤0.01% 5619
2023
Q1
$364K Buy
36,942
+35,307
+2,159% +$347K ﹤0.01% 3805
2022
Q4
$30.6K Sell
1,635
-1,269
-44% -$23.8K ﹤0.01% 4770
2022
Q3
$60K Sell
2,904
-497
-15% -$10.3K ﹤0.01% 4564
2022
Q2
$71K Sell
3,401
-4,816
-59% -$101K ﹤0.01% 4583
2022
Q1
$354K Sell
8,217
-11,947
-59% -$515K ﹤0.01% 4363
2021
Q4
$1.21M Buy
20,164
+3,859
+24% +$231K ﹤0.01% 3726
2021
Q3
$1.4M Buy
16,305
+5,731
+54% +$493K ﹤0.01% 3750
2021
Q2
$1.18M Buy
10,574
+581
+6% +$64.6K ﹤0.01% 3883
2021
Q1
$1.11M Sell
9,993
-24,764
-71% -$2.76M ﹤0.01% 3914
2020
Q4
$3.69M Buy
34,757
+2,366
+7% +$251K ﹤0.01% 2979
2020
Q3
$4.51M Sell
32,391
-2,016
-6% -$281K ﹤0.01% 2582
2020
Q2
$11.1M Buy
34,407
+27,583
+404% +$8.92M ﹤0.01% 1759
2020
Q1
$609K Buy
6,824
+65
+1% +$5.8K ﹤0.01% 3784
2019
Q4
$268K Sell
6,759
-9,551
-59% -$379K ﹤0.01% 4651
2019
Q3
$401K Buy
16,310
+552
+4% +$13.6K ﹤0.01% 4399
2019
Q2
$556K Sell
15,758
-6,092
-28% -$215K ﹤0.01% 4196
2019
Q1
$978K Buy
21,850
+7,892
+57% +$353K ﹤0.01% 3857
2018
Q4
$670K Buy
13,958
+7,465
+115% +$358K ﹤0.01% 4040
2018
Q3
$434K Buy
6,493
+199
+3% +$13.3K ﹤0.01% 4418
2018
Q2
$296K Sell
6,294
-8,862
-58% -$417K ﹤0.01% 4668
2018
Q1
$857K Buy
15,156
+239
+2% +$13.5K ﹤0.01% 3954
2017
Q4
$739K Buy
14,917
+6,277
+73% +$311K ﹤0.01% 4035
2017
Q3
$657K Buy
8,640
+1,195
+16% +$90.9K ﹤0.01% 4062
2017
Q2
$701K Sell
7,445
-2,935
-28% -$276K ﹤0.01% 3912
2017
Q1
$825K Buy
10,380
+2,324
+29% +$185K ﹤0.01% 3814
2016
Q4
$671K Buy
8,056
+1,213
+18% +$101K ﹤0.01% 3906
2016
Q3
$765K Buy
6,843
+16
+0.2% +$1.79K ﹤0.01% 3598
2016
Q2
$757K Buy
6,827
+208
+3% +$23.1K ﹤0.01% 3598
2016
Q1
$693K Buy
6,619
+573
+9% +$60K ﹤0.01% 3583
2015
Q4
$487K Buy
6,046
+573
+10% +$46.2K ﹤0.01% 3833
2015
Q3
$379K Sell
5,473
-24
-0.4% -$1.66K ﹤0.01% 3990
2015
Q2
$538K Buy
5,497
+1,450
+36% +$142K ﹤0.01% 3957
2015
Q1
$396K Buy
4,047
+3,814
+1,637% +$373K ﹤0.01% 3988
2014
Q4
$26K Sell
233
-39
-14% -$4.35K ﹤0.01% 5048
2014
Q3
$32K Sell
272
-427
-61% -$50.2K ﹤0.01% 4962
2014
Q2
$90K Buy
699
+149
+27% +$19.2K ﹤0.01% 4612
2014
Q1
$88K Buy
+550
New +$88K ﹤0.01% 4613